Skip to main content

Table 1 List of participating hospitals

From: A multicentric, single arm, open-label, phase I/II study evaluating PSMA targeted radionuclide therapy in adult patients with metastatic clear cell renal cancer (PRadR)

No

Center

Site

Principal investigator

1

Centre Léon Bérard (sponsor)

Lyon (France)

Anne Laure Giraudet (MD)

2

Centre Jean Perrin

Clermont Ferrand (France)

Hakim Mahammedi (MD)

3

CHU Bordeaux

Bordeaux (France)

Marie Meyer (MD)

4

CHU Grenoble

Grenoble (France)

Loïc Djaleb (MD)